These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5514471)

  • 1. Survival time of mice bearing Ehrlich ascites tumor, with special reference to the effect of hydrocortisone administration.
    Kodama M; Amo H; Kodama T
    J Natl Cancer Inst; 1970 May; 44(5):1055-64. PubMed ID: 5514471
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing effect of hydrocortisone acetate administration on the content of A-type particles in Ehrlich ascites tumor.
    Kodama T; Kodama M; Nishi Y
    J Natl Cancer Inst; 1984 Jul; 73(1):227-31. PubMed ID: 6588227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of Ehrlich carcinoma recurrence and metastasis].
    Donenko FV; Sitdikova SM; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Dec; 114(12):652-4. PubMed ID: 1292704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential surface structures of invasive and non-invasive Ehrlich ascites tumor cell lines with special reference to the effect of hydrocortisone treatment.
    Kodama M; Kodama T; Nishi Y
    Anticancer Res; 1992; 12(4):1217-21. PubMed ID: 1503412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiosensitizing and toxic action of metronidazole and isometronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole) on the cells of Ehrlich ascites cancer and hemoblastosis La in vitro].
    Proskuriakov SIa; Smoryzanova OA; Dedenkov AN; Riabchenko NI
    Radiobiologiia; 1986; 26(6):766-70. PubMed ID: 3809411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell division in Ehrlich ascites tumor and survival of mice after administration of chalone].
    Savchenko TV; Zakharov VB; Mamontov SG; Romanov IuA
    Vestn Akad Med Nauk SSSR; 1980; (11):54-9. PubMed ID: 6451996
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lysolecithin and analogs on mouse ascites tumors.
    Tarnowski GS; Mountain IM; Stock CC; Munder PG; Weltzien HU; Westphal O
    Cancer Res; 1978 Feb; 38(2):339-44. PubMed ID: 620405
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancing effect of hydrocortisone on hematogenous metastasis of Ehrlich ascites tumor in mice.
    Kodama M; Kodama T
    Cancer Res; 1975 Apr; 35(4):1015-21. PubMed ID: 1116140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The time dependent, electronically measured change in volume frequency distribution of Ehrlich ascites tumor cells after treatment with alkylating cytostatics in vivo].
    Gutsche W
    Arzneimittelforschung; 1971 Apr; 21(4):444-6. PubMed ID: 5108137
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor.
    Dano K
    Cancer Chemother Rep; 1971 Apr; 55(2):133-41. PubMed ID: 5118683
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of phenylalanine-enriched diet on growth of Ehrlich ascites tumor cells.
    Yanagi S; Noguchi T; Imamura K; Tanaka T
    Gan; 1974 Oct; 65(5):423-7. PubMed ID: 4435342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of epsilon-aminocaproic acid on the growth of tumor cells in immunized mice].
    Bonmassar E; Celi ML; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):187-94. PubMed ID: 5745501
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of the nitrofuran derivatives against Ehrlich ascites tumor.
    Kikui M
    Med J Osaka Univ; 1968 Dec; 19(2):127-41. PubMed ID: 4900418
    [No Abstract]   [Full Text] [Related]  

  • 15. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
    Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
    Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Population size and calculation of the generation time of Ehrlich ascites carcinoma cells].
    Il'ina KP; Merkle K
    Vopr Onkol; 1973; 19(1):70-4. PubMed ID: 4701927
    [No Abstract]   [Full Text] [Related]  

  • 18. Melatonin shortens the survival rate of Ehrlich ascites-inoculated mice.
    Catrina SB; Curca E; Catrina AI; Radu C; Coculescu M
    Neuro Endocrinol Lett; 2001 Dec; 22(6):432-4. PubMed ID: 11781540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiosensitizing and damaging effects of hyperthermia on different biological systems. Ehrlich ascites carcinoma cells].
    Shteĭn LV; Konopliannikov AG
    Radiobiologiia; 1983; 23(6):770-3. PubMed ID: 6361843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of BCG on the survival of mice following intraperitoneal administration of Ehrlich ascites tumor cells].
    Jakóbisiak M; Kossakowska AE; Zelechowska M; Kamiński M
    Med Dosw Mikrobiol; 1974; 26(3):235-40. PubMed ID: 4409404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.